New paradigm in the way glaucoma is diagnosed

Article

Suggesting a change in the way physicians diagnose glaucoma, Robert Weinreb, MD, outlined a new paradigm for diagnosis of the disease in his Glaucoma Society of International Ophthalmology Congress (GCIOC) Day Lecture, presented Monday at the World Ophthalmology Congress. Dr. Weinreb said that the glaucoma field is undergoing a revolution in diagnosis. He said there is a transition from reliance solely on visual fields to the increased use of structural analysis of the optic disk and RNFL. "It's something that was initiated 20 years ago," explained Dr. Weinreb. "Changes are very, very slow in glaucoma, as it does in all medical disciplines. We have reached an infliction point in glaucoma diagnosis where we are about to reap the benefits of this revolution."

Suggesting a change in the way physicians diagnose glaucoma, Robert Weinreb, MD, outlined a new paradigm for diagnosis of the disease in his Glaucoma Society of International Ophthalmology Congress (GCIOC) Day Lecture, presented Monday at the World Ophthalmology Congress.

Dr. Weinreb said that the glaucoma field is undergoing a revolution in diagnosis. He said there is a transition from reliance solely on visual fields to the increased use of structural analysis of the optic disk and RNFL.

"It's something that was initiated 20 years ago," explained Dr. Weinreb. "Changes are very, very slow in glaucoma, as it does in all medical disciplines. We have reached an infliction point in glaucoma diagnosis where we are about to reap the benefits of this revolution."

Dr. Weinreb, director of the Hamilton Glaucoma Center at the University of California, San Diego, proceed to discuss the diagnosis of glaucoma. Citing that glaucoma is a continuum where a patient progresses from a non-detectable disease to asystematic disease, glaucoma is detected by a change in visual function or change in the appearance of the optic disk or RNFL.

The number of patients who have glaucoma worldwide is not really known, Dr. Weinreb pointed out. It's estimated that between 70 million to 100 million people have glaucoma. "The key point is that at least half of the patients with glaucoma are not recognized. Between 90% to 95% who have glaucoma don't know they have glaucoma, and have not yet been diagnosed with it."

He then reviewed the standard by which glaucoma is currently detected, including the assessment of standard visual field and standard automatic perimetry, with years of long follow-up periods to monitor the progression of glaucoma in patients.

Dr. Weinreb explained that the paradigm for glaucoma diagnosis and the changing concept would center on the assessments of the optic disk and RNFL along with visual function. They will be essential elements to quality glaucoma diagnosis.

"Glaucoma can be defined as a common structural or structural-functional abnormality," Dr. Weinreb said. "Glaucoma can also be defined as a progressive structural or functional change, such as the progressive change in the disk, RNFL, or the visual field. That's probably the most specific diagnosis for glaucoma."

He concluded that slight functional testing complements standard automated perimetry and facilitates the earlier diagnosis. The evaluation of the documentation of the optic disk and the RNFL enhance glaucoma diagnosis. Structural and functional testing provides complementary information for sensitive and specific glaucoma diagnosis.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.